7148 DPHARMA | Malaysia

DUOPHARMA BIOTECH BERHAD

RM 2.85 on: 2021-07-23

-0.35% Past 1-day return
-1.72% Past 5-day return

Covid19 Upside Pharmaceuticals


Price/Valuation Analysis
Current Price Status
  • Stock is in Momentum

    Stock is currently overvalued by the market with the expectation of annual earning growth at 44.01% to match current price.

    Overvalued stock can be traded very volatile. If the earning growth momentum continue, overvalued stock can match into fair value, on the flip side, the downside risk can be huge if the stock is not meeting the market expectation.

  • Company is in Positive Earning
Fair Value
  • DPHARMA current price is 12.2% above OneDelta estimated fair value.
  • The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.

Relative Price Performance
  • Underperformed
    DPHARMA past 5-day return lagged behind the Pharmaceuticals industry average return by 1.64%
  • Below 30-Day Average
    Current price RM2.85 is below 30-day average RM3.01 by 5.6%

Return (%) DPHARMA Pharmaceuticals
1-Day-0.35% -0.36%
5-Day-1.72% -0.08%
30-Day-10.09% -12.25%
Bank Analyst Price Targets
No recent bank analyst price target available yet
Revenue & Earning Growth Analysis
  • Cyclical Revenue Growth

    DPHARMA recorded various revenue growth in different quarters with no clear growth direction.

  • Unstable Profit Growth

    DPHARMA has been experiencing substantial ups and downs on profit growth.


Past Quarter Reports
Quarter Date Revenue (RM) (%) EPS (RM) (%)
2020-12-31 134,086k +0% 0.0229 +13%
2020-09-30 133,772k -7% 0.0203 -6%
2020-06-30 143,331k -10% 0.0215 +9%
2020-03-31 158,713k +15% 0.0198 +13%
2019-12-31 137,755k -4% 0.0176 -20%
Volume Trend Analysis
  • Recent Volume is Decreasing

    Decreasing trading volume tends to keep stock price range bound in near term.

  • DPHARMA recent daily traded volume is -25% lower than past month average.

Past 30-Day Past 5-Day
16k daily12k daily
Financials
Price History Chart
Past 30-day Average Price: RM3.01
Stock Fundamental Factors

Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.

Stock Thematic Baskets

Usually the more the stock is included in popular themes, the more opportunity for price-driven momentum and better liquidity.

Stock Company Profile
DUOPHARMA BIOTECH BERHAD

Duopharma Biotech Bhd. is an investment holding company, which engages in the research, development, and commercialization of chemical and pharmaceutical products. Its products include tablets, capsules, syrup, antibiotic, creams, haemodialysis solution, sterile irrigation solution, sterile powder injectibles, small volume injectibles, dental cartridges, and eye drop preparations. The company was founded in 1979 and is headquartered in Klang, Malaysia.